🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Healthy Human Volunteers

A Phase 1 Study of PVT401 in Healthy Subjects NCT07423000Phase 11 site📍 Melbourne Parvus Therapeutics, Inc. · Tests: PVT401, Normal Saline (0.9% NaCl) A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants NCT07836452Phase 11 site📍 Melbourne City Therapeutics · Tests: CITY-RBP4, Placebo A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants NCT07736638Phase 12 sites📍 Anaheim📍 Grayslake AbbVie · Tests: ABBV-859, Placebo for ABBV-859, ABBV-859, Placebo for ABBV-859 SAD and MAD Study of AKB-9090 in Healthy Adult Participants NCT07429006Phase 11 site📍 Auckland Akebia Therapeutics · Tests: AKB-9090, Placebo Investigating the Plasticity of Human Predictive Coding Through Neuromodulation NCT06374433NA1 site📍 Milan Università Vita-Salute San Raffaele · Tests: Occipital tACS at IAF-2Hz, Occipital tACS at IAF+2Hz, Frontal tACS at 4-7 Hz, Occipital tRNS, Frontal tRNS Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge NCT02639299n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Study of TRX-100 Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers NCT07526506Phase 11 site📍 Randwick Traws Pharma, Inc. · Tests: TRX-100, Placebo SAR447971 First-in-human Study NCT07629336Phase 11 site📍 Leiden Sanofi · Tests: SAR447971, Placebo A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease NCT06481306Phase 1, Phase 232 sites📍 Birmingham📍 La Jolla📍 Oakland Bristol-Myers Squibb · Tests: BMS-986470, Placebo, Famotidine, Pantoprazole Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older NCT07734649Phase 1, Phase 250 sites📍 Gadsden📍 Vestavia Hills📍 Huntington Beach Sanofi · Tests: RSV+HMPV vaccine, Control Vaccine 3, Control Vaccine 4, Control Vaccine 2, Placebo EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1) NCT07047703Phase 1, Phase 216 sites📍 Birtinya📍 Morayfield📍 Perth Grey Wolf Therapeutics · Tests: Part A - Single Ascending Dose (SAD) in Healthy Human Volunteers, Part B - Multiple Ascending Dose (MAD) in participant… Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above. NCT07779408Phase 1, Phase 216 sites📍 Tempe📍 Rolling Hills Estates📍 San Diego Sanofi · Tests: Flu H5 egg pandemic low dose vaccine, with adjuvant, Flu H5 Egg Pandemic medium dose vaccine, with adjuvant, Flu H5 Egg… First-in-human Study of HSK56630 in Healthy Subjects NCT07580794Phase 11 site📍 Bayswater Haisco Pharmaceutical Group Co., Ltd. · Tests: HSK56630, Placebo Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016 NCT07615985Phase 11 site📍 Brisbane Pulmongene Ltd. · Tests: PMG1016 Dose 1, PMG1016 Dose 2, PMG1016 Dose 3, PMG1016 Dose 4 Safety and Tolerability of ZE74-0282 in Healthy Volunteers NCT07527221Phase 11 site📍 Randwick Eilean Therapeutics AU Pty Ltd · Tests: ZE74-0282-0001 or placebo Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle NCT01266577NA1 site📍 Bethesda National Institute of Mental Health (NIMH) · Tests: NSR MAGNETOM 7T, 1Tx x 32Rx Head Coil A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants NCT06682975Phase 11 site📍 Leiden Zealand Pharma · Tests: ZP9830, Placebo Screening for LID Clinical Studies Unit Healthy Volunteer Protocols NCT01386424n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A First-in-Human Study of PRD001 NCT07034183Phase 11 site📍 Fukuoka PRD Therapeutics, Inc. · Tests: PRD001, Placebo A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis NCT07604324Phase 11 site📍 Fukuoka Novartis Pharmaceuticals · Tests: DCY636, Placebo A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a Single Dose of REGN22044 in Healthy Adults NCT07526116Phase 11 site📍 Ghent Regeneron Pharmaceuticals · Tests: REGN22044, Placebo Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe NCT07282795n/a15 sites📍 Goyang-si📍 Gunpo📍 Busan Sanofi · Tests: Efluelda® Pre-filled syringe Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers NCT06859333Phase 11 site📍 Moscow Valenta Pharm JSC · Tests: Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-… A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects NCT05913752Phase 1, Phase 24 sites📍 New Haven📍 Baltimore📍 Jerusalem Clearmind Medicine Inc. · Tests: CMND-100 Single-dose,First-in-human of KLA478 NCT07240675Phase 11 site📍 Shanghai Hunan Kelun Pharmaceutical Co., Ltd. · Tests: pramipexole hydrochloride sustained-release tablets, KLA478, placebo A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects NCT07223333Phase 13 sites📍 Chandler📍 Miami📍 Port Orange AdipoPharma LLC · Tests: PATAS Trifluoroacetate, Placebo A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma NCT07660731Phase 11 site📍 New Haven Pfizer · Tests: PF-08103402, Placebo, Midazolam First-in-Human Single and Multiple Dose of KLA578-1 for Injection NCT07143318Phase 11 site📍 Changsha Hunan Kelun Pharmaceutical Co., Ltd. · Tests: KLA578-1 for injection, Etopcoxib Tablets Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body NCT06645691Phase 21 site📍 Singapore National Heart Centre Singapore · Tests: Hyperpolarized 13C-pyruvate A First-in Human Study of ARD001 in Healthy Volunteers and People With Hemophilia A NCT07787091Phase 1, Phase 21 site📍 Singapore Arditus Pte Ltd · Tests: ARD001, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy